Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12788/jhm.3594 http://scihub22266oqcxt.onion/10.12788/jhm.3594 34129486!ä!34129486 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Hosp+Med 2021 ; 16 (6): 349-352 Nephropedia Template TP {{tp|p=34129486|t=2021. Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 |pdf=|usr=}}{{34129486}} gab.com Text Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 JO: J Hosp Med http://www.kidney.de/pget.php?&tw=1&pmid=34129486 #FOAvip Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent with a more severe COVID-19 infection (eg, significantly higher C-reactive protein, troponin, transaminases, lymphocytopenia, thrombocytopenia, and ferritin). Systemic inflammatory response syndrome, bilateral pneumonia, respiratory insufficiency, and renal failure were significantly more frequent in men. Men more often required pronation, corticosteroids, and tocilizumab administration. A significantly higher 30-day mortality was observed in men vs women (23.4% vs 19.2%; P = .039). Trial Numbers: NCT04334291/EUPAS34399. Twit Text FOAVip Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 ????J Hosp Med http://www.kidney.de/pget.php?&tw=1&pmid=34129486 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34129486 #FOAvip English Wikipedia <ref>{{Cite pmid|34129486}}</ref> Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 #MMPMID34129486 Biole C; Bianco M; Nunez-Gil IJ; Cerrato E; Spirito A; Roubin SR; Viana-Llamas MC; Gonzalez A; Castro-Mejia AF; Eid CM; Fernandez-Perez C; Uribarri A; Alfonso-Rodriguez E; Ugo F; Guerra F; Feltes G; Akin I; Fernandez-Rozas I; Blasco-Angulo N; Huang J; Aguado MG; Pepe M; Romero R; Becerra-Munoz VM; Estrada V; Macaya C J Hosp Med 2021[Jun]; 16 (6): 349-352 PMID34129486show ga Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent with a more severe COVID-19 infection (eg, significantly higher C-reactive protein, troponin, transaminases, lymphocytopenia, thrombocytopenia, and ferritin). Systemic inflammatory response syndrome, bilateral pneumonia, respiratory insufficiency, and renal failure were significantly more frequent in men. Men more often required pronation, corticosteroids, and tocilizumab administration. A significantly higher 30-day mortality was observed in men vs women (23.4% vs 19.2%; P = .039). Trial Numbers: NCT04334291/EUPAS34399. |*Hospitalization[MESH] |*Sex Factors[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*diagnosis/mortality[MESH] |Cohort Studies[MESH] |Comorbidity[MESH] |Disease Progression[MESH] |Female[MESH] |Heart Disease Risk Factors[MESH] |Humans[MESH] |Male[MESH]Gender Differences in the Presentation and Outcomes of Hospitalized Pa(epmc).pdf DeepDyve Pubget Overpricing